ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 284751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 284751; 2) Community: the network communities that were significantly associated with the response to NSC 284751; 3) Molecule: the relationships between components within communities and NSC 284751; 4) MDR: the compounds that were significantly associated with the NSC 284751.

NSC Compound Enrichment Correlation
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0164116791870036 0.44620893
NSC 604976 Verrucarin A, 7'-deoxo-2'-deoxy-2',3'-epoxy-8',9',10',11'- tetrahydro-4',8-dihydroxy-7'-(1-hydroxyethyl)- 0.0164116791870036 -0.062208427
NSC 606497 Camptothecin Derivative 0.0164116791870036 0.31338312
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0164116791870036 0.32833825
NSC 624657 ANTINEOPLASTIC-624657 0.0164116791870036 0.21444365
NSC 636969 Null 0.0164116791870036 0.4123028
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0164116791870036 0.41375099
NSC 659608 Null 0.0164116791870036 0.43192892
NSC 672974 Null 0.0164116791870036 0.39055291
NSC 674268 Null 0.0164116791870036 0.37486816
Total:146  Current:63    [First] [Prev] [Next] [Last]